This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Crown Bioscience Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Ying Jin - Innovator in Anti-CD4 Antibodies
Introduction
Ying Jin is a notable inventor based in Taicang, China. He has made significant contributions to the field of biotechnology, particularly in the development of anti-CD4 antibodies. His work has implications for various therapeutic applications, showcasing his innovative spirit and dedication to advancing medical science.
Latest Patents
Ying Jin holds a patent for anti-CD4 antibodies. The patent details the provision of anti-CD4 antibodies or antigen-binding fragments, isolated polynucleotides encoding the same, pharmaceutical compositions comprising these antibodies, and their various uses. This innovation represents a crucial step in the development of targeted therapies.
Career Highlights
Ying Jin is currently associated with Crown Bioscience Inc., a company known for its focus on preclinical research and development services. His role at the company allows him to leverage his expertise in biotechnology and contribute to groundbreaking research.
Collaborations
Ying Jin has collaborated with esteemed colleagues, including Ziyong Sun and Wencui Ma. These partnerships enhance the research environment and foster innovation within the field.
Conclusion
Ying Jin's work in the development of anti-CD4 antibodies exemplifies his commitment to advancing medical science through innovation. His contributions are vital to the ongoing research in therapeutic applications, and his collaborations further strengthen the impact of his work.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile